175 related articles for article (PubMed ID: 20582812)
1. Evaluation of in vitro activity of carvacrol against Candida albicans strains.
Vardar-Unlu G; Yağmuroğlu A; Unlu M
Nat Prod Res; 2010 Jul; 24(12):1189-93. PubMed ID: 20582812
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of anti-Candida potential of geranium oil constituents against clinical isolates of Candida albicans differentially sensitive to fluconazole: inhibition of growth, dimorphism and sensitization.
Zore GB; Thakre AD; Rathod V; Karuppayil SM
Mycoses; 2011 Jul; 54(4):e99-109. PubMed ID: 20337938
[TBL] [Abstract][Full Text] [Related]
3. [Short communication: In vitro activity of amphotericin B with fluconazole or voriconazole combinations against Candida albicans isolates].
Oz Y; Akşit F; Kiraz N; Kiremitçi A
Mikrobiyol Bul; 2008 Jan; 42(1):149-55. PubMed ID: 18444574
[TBL] [Abstract][Full Text] [Related]
4. In vitro activity of 2-cyclohexylidenhydrazo-4-phenyl-thiazole compared with those of amphotericin B and fluconazole against clinical isolates of Candida spp. and fluconazole-resistant Candida albicans.
De Logu A; Saddi M; Cardia MC; Borgna R; Sanna C; Saddi B; Maccioni E
J Antimicrob Chemother; 2005 May; 55(5):692-8. PubMed ID: 15772140
[TBL] [Abstract][Full Text] [Related]
5. Potential fungicidal effect of voriconazole against Candida spp.
Rubio MC; de Ocáriz IR; Gil J; Benito R; Rezusta A
Int J Antimicrob Agents; 2005 Mar; 25(3):264-7. PubMed ID: 15737524
[TBL] [Abstract][Full Text] [Related]
6. Interaction of carvacroland voriconazole against drug - resistant Candida strains isolated from patients with candidiasis.
Sharifzadeh A; Shokri H; Abbaszadeh S
J Mycol Med; 2019 Apr; 29(1):44-48. PubMed ID: 30554935
[TBL] [Abstract][Full Text] [Related]
7. [Comparison of broth microdilution and E-test methods for the antifungal susceptibility testing of Candida spp. strains isolated from blood cultures].
Ozcan SK; Mutlu B; Dündar D; Willke A
Mikrobiyol Bul; 2010 Apr; 44(2):263-71. PubMed ID: 20549961
[TBL] [Abstract][Full Text] [Related]
8. Susceptibility profile of vaginal isolates of Candida albicans prior to and following fluconazole introduction - impact of two decades.
Bulik CC; Sobel JD; Nailor MD
Mycoses; 2011 Jan; 54(1):34-8. PubMed ID: 19563489
[TBL] [Abstract][Full Text] [Related]
9. In vitro activity of fluconazole on Candida albicans.
Abecia LC; Arévalo JM; López MJ
Microbiologia; 1996 Dec; 12(4):613-20. PubMed ID: 9018696
[TBL] [Abstract][Full Text] [Related]
10. Study of anticandidal activity of carvacrol and eugenol in vitro and in vivo.
Chami N; Bennis S; Chami F; Aboussekhra A; Remmal A
Oral Microbiol Immunol; 2005 Apr; 20(2):106-11. PubMed ID: 15720571
[TBL] [Abstract][Full Text] [Related]
11. In vitro synergic antifungal effect of MUC7 12-mer with histatin-5 12-mer or miconazole.
Wei GX; Bobek LA
J Antimicrob Chemother; 2004 May; 53(5):750-8. PubMed ID: 15073161
[TBL] [Abstract][Full Text] [Related]
12. [Antifungal activity of itraconazole and ketoconazole investigated in vitro, determined with minimal inhibitory concentrations and mycelial cell transformation in Candida albicans].
Urbanowski S; Nierebińska E; Gwieździński Z
Przegl Dermatol; 1989; 76(5-6):405-9. PubMed ID: 2561925
[TBL] [Abstract][Full Text] [Related]
13. In vitro antifungal activity of N-3-(1,2,4-dithiazole-5-thione)-beta-resorcylcarbothioamide.
Niewiadomy A; Krajewska-Kułak E; Lukaszuk C; Matysiak J; Kostecka M
Rocz Akad Med Bialymst; 2005; 50 Suppl 1():31-5. PubMed ID: 16119621
[TBL] [Abstract][Full Text] [Related]
14. Terpenoids inhibit Candida albicans growth by affecting membrane integrity and arrest of cell cycle.
Zore GB; Thakre AD; Jadhav S; Karuppayil SM
Phytomedicine; 2011 Oct; 18(13):1181-90. PubMed ID: 21596542
[TBL] [Abstract][Full Text] [Related]
15. In vitro activity of inexpensive topical alternatives against Candida spp. isolated from the oral cavity of HIV-infected patients.
Traboulsi RS; Mukherjee PK; Ghannoum MA
Int J Antimicrob Agents; 2008 Mar; 31(3):272-6. PubMed ID: 18242063
[TBL] [Abstract][Full Text] [Related]
16. Activated lactoferrin and fluconazole synergism against Candida albicans and Candida glabrata vaginal isolates.
Naidu AS; Fowler RS; Martinez C; Chen J; Tulpinski J
J Reprod Med; 2004 Oct; 49(10):800-7. PubMed ID: 15568403
[TBL] [Abstract][Full Text] [Related]
17. In vitro activities of isavuconazole and other antifungal agents against Candida bloodstream isolates.
Seifert H; Aurbach U; Stefanik D; Cornely O
Antimicrob Agents Chemother; 2007 May; 51(5):1818-21. PubMed ID: 17307977
[TBL] [Abstract][Full Text] [Related]
18. Activities of micafungin against 315 invasive clinical isolates of fluconazole-resistant Candida spp.
Messer SA; Diekema DJ; Boyken L; Tendolkar S; Hollis RJ; Pfaller MA
J Clin Microbiol; 2006 Feb; 44(2):324-6. PubMed ID: 16455878
[TBL] [Abstract][Full Text] [Related]
19. [In vitro activities of posaconazole, fluconazole, itraconazole, ketoconazole and voriconazole against Candida glabrata].
Blanco MT; Cañadas J; García-Martos P; Marín P; García-Tapia A; Rodríguez J
Rev Esp Quimioter; 2009 Sep; 22(3):139-43. PubMed ID: 19662547
[TBL] [Abstract][Full Text] [Related]
20. In vitro susceptibility of Candida species to five antifungal agents in a German university hospital assessed by the reference broth microdilution method and Etest.
Fleck R; Dietz A; Hof H
J Antimicrob Chemother; 2007 Apr; 59(4):767-71. PubMed ID: 17293369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
